Table 1. Infection risk associated with disease-related inherent immune defects

 DiseaseDisease-related inherent immune defects 
Chronic lymphocytic leukemia 
  • Hypogammaglobulinemia

  • Complement defects

  • Cell-mediated immune defects (T-cells, delayed hypersensitivity)

  • Neutrophil phagocytic/bactericidal activity defects

  • Monocyte function/deficiencies in monocyte enzyme levels

  • Potential mucosal immune defects

 
Multiple myeloma 
  • Hypogammaglobulinemia

  • Complement defects

  • Cellular immune impairment

  • Delayed hypersensitivity creating abnormal recall response

  • Abnormal T cell response to mitogens

  • Defective response to immunization

  • Neutrophil phagocytic/bactericidal activity defects

 
Hairy cell leukemia 
  • Quantitative and qualitative defect of monocytes

  • Cytokine induced suppression

  • Depressed T-cell function

  • Immune defects related to therapeutic splenectomy

 
Hodgkin lymphoma 
  • Abnormalities in cell-mediated immunity

  • Qualitative and quantitative lymphocyte abnormalities

  • Low T lymphocyte counts and impaired lymphocyte function

  • State of cell-mediated suppression

  • Delayed hypersensitivity response to recall

  • Impaired proliferative responses

 
Non-Hodgkin lymphoma 
  • Congenital and acquired states of immunosuppression (Ataxia-telangiectasia, Wiskott-Aldrich syndrome, common variable hypogammaglobulinemia, X-linked lymphoproliferative syndrome, and severe combined immunodeficiency, HIV EBV)

  • T cells and NK cell failure

  • Depression of regulatory T cells, suppressing T cell activity and resulting in further immune dysfunction

 
 DiseaseDisease-related inherent immune defects 
Chronic lymphocytic leukemia 
  • Hypogammaglobulinemia

  • Complement defects

  • Cell-mediated immune defects (T-cells, delayed hypersensitivity)

  • Neutrophil phagocytic/bactericidal activity defects

  • Monocyte function/deficiencies in monocyte enzyme levels

  • Potential mucosal immune defects

 
Multiple myeloma 
  • Hypogammaglobulinemia

  • Complement defects

  • Cellular immune impairment

  • Delayed hypersensitivity creating abnormal recall response

  • Abnormal T cell response to mitogens

  • Defective response to immunization

  • Neutrophil phagocytic/bactericidal activity defects

 
Hairy cell leukemia 
  • Quantitative and qualitative defect of monocytes

  • Cytokine induced suppression

  • Depressed T-cell function

  • Immune defects related to therapeutic splenectomy

 
Hodgkin lymphoma 
  • Abnormalities in cell-mediated immunity

  • Qualitative and quantitative lymphocyte abnormalities

  • Low T lymphocyte counts and impaired lymphocyte function

  • State of cell-mediated suppression

  • Delayed hypersensitivity response to recall

  • Impaired proliferative responses

 
Non-Hodgkin lymphoma 
  • Congenital and acquired states of immunosuppression (Ataxia-telangiectasia, Wiskott-Aldrich syndrome, common variable hypogammaglobulinemia, X-linked lymphoproliferative syndrome, and severe combined immunodeficiency, HIV EBV)

  • T cells and NK cell failure

  • Depression of regulatory T cells, suppressing T cell activity and resulting in further immune dysfunction

 

EBV, Epstein-Barr virus; NK, natural killer.

or Create an Account

Close Modal
Close Modal